{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:37:07Z","timestamp":1793371027059,"version":"4.5.0"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010225","name":"National Outstanding Youth Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015378","name":"Shanghai Institute of Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015378","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaad.2026.10.001","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:02:17Z","timestamp":1791388937000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Necrotic eruptions indicate severe myositis in immune checkpoint inhibitor-associated dermatomyositis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4990-4582","authenticated-orcid":false,"given":"Wenxi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.10.001_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10637-020-00974-7","article-title":"Anti-transcriptional intermediary factor 1-\u03b3 antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: a case report","volume":"39","author":"Osaki","year":"2021","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jaad.2026.10.001_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.resinv.2024.01.009","article-title":"Rapidly progressive interstitial lung disease with positive anti-MDA5 antibody as an immune-related complication of nivolumab: a case report","volume":"62","author":"Kato","year":"2024","journal-title":"Respir Investig"},{"key":"10.1016\/j.jaad.2026.10.001_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s44272-025-00043-1","article-title":"Multi-disciplinary expert consensus on cutaneous adverse events caused by immune checkpoint inhibitors (2025)","volume":"4","author":"Sun","year":"2025","journal-title":"Clin Cancer Bull"},{"key":"10.1016\/j.jaad.2026.10.001_bib4","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1093\/rheumatology\/keaa832","article-title":"Anti-TIF1\u03b3 antibody-positive dermatomyositis in a 15-year-old boy with Epstein-Barr virus-related nasopharyngeal cancer receiving nivolumab","volume":"60","author":"Asano","year":"2021","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226036868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226036868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:28:27Z","timestamp":1793370507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226036868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":4,"alternative-id":["S0190962226036868"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.10.001","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Necrotic eruptions indicate severe myositis in immune checkpoint inhibitor-associated dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}